Four-Component Recombinant Protein-Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy.
Lodi L, Barbati F, Amicizia D, Baldo V, Barbui AM, Bondi A, Costantino C, Da Dalt L, Ferrara L, Fortunato F, Guarnieri V, Icardi G, Indolfi G, Martinelli D, Martini M, Moriondo M, Nieddu F, Peroni DG, Prato R, Ricci S, Russo F, Tirelli F, Vitale F, Ladhani SN, Azzari C; Multiregional MenB study group.
Lodi L, et al.
JAMA Netw Open. 2023 Aug 1;6(8):e2329678. doi: 10.1001/jamanetworkopen.2023.29678.
JAMA Netw Open. 2023.
PMID: 37594762
Free PMC article.